Abstract
Introduction
Several biochemical mechanisms contribute to b-adrenw x ergic receptor desensitization 1 . Most importantly, agonist-occupied active receptors become phosphorylated by Ž . w x the specific b-adrenergic receptor kinase bARK 1,2 , facilitating the subsequent binding of the inhibitor protein, w x b-arrestin, to the receptors 3 . Thereby, receptor function ( )w x mRNA levels in human heart failure 6 . This activation specifically involved the mRNA for bARK-1, but not for w x bARK-2 or for b-arrestin 7 . The activation of bARK seems to be a very early event during the development of heart failure, since it preceded the alterations of b-receptor density or of G-proteins in the model of pacing-induced w x heart failure in the pig 8 . Chronic exposure to b-blockers, in turn, decreased cardiac bARK activity in cytosol and w x membranes 9 . Also, cardiac ischemia increases bARK w x activity in cardiac membranes 10 .
Pivotal work by Lefkowitz and collaborators has shown that activation of bARK is closely related to a translocation of the enzyme from the cytosol to the membranes. bARK membrane targeting is specifically mediated by G-protein bg-subunits. bg-Subunits can bind to the pleck-Ž . strin-homology PH domain, which forms part of the w x COOH-terminus of bARK 11,12 . Overexpression of the Ž COOH-terminus of bARK-1 amino acids 495-689, . 'bARKmini' has subsequently been shown to exert a 'scavenging' effect on a variety of mechanisms mediated by bg-subunits, such as a -adrenergic receptor-mediated 2 w x stimulation of adenylyl cyclase II 13 , or muscarinic M -2 w x stimulated inositol phosphate turnover 13 . 'bARKmini' also inhibits Gbg-stimulated phosphorylation of rhodopsin w x in vitro 14 . Most importantly, overexpression of 'bARKmini' in the hearts of transgenic mice also improved cardiac contractility, as demonstrated by heart w x catheterization in vivo 14 . Up to now, however, direct evidence for the role of 'bARKmini' on bARK translocation in intact cells and in myocytes has not been provided. Generally, bARK translocation has been investigated in isolated, prepared cell fractions, instead of whole cells. Moreover, the inhibitory effect of 'bARKmini' on adenylyl cyclase activity has only been shown in reconstituted w x systems of recombinant proteins 15 . In contrast, direct effects of 'bARKmini' on endogenous b-adrenergic desensitization in myocytes have not been demonstrated, since adenylyl cyclase activity in myocardial membranes w x was not altered by 'bARKmini' 14 .
Therefore, we set out to characterize bARK translocation directly in intact myocytes. Similarly, we intended to investigate more precisely the effects of 'bARKmini' on the endogenous b-adrenergic system in cardiomyocytes. Thereby, we sought to determine adequate gene concentrations of 'bARKmini' needed for relevant inhibition of b-adrenergic desensitization in smooth muscle cells and in cardiomyocytes.
Methods

Cell culture
DDT-MF-2 smooth muscle cells derived from hamster ductus deferens leiomyosarcoma were a kind gift of M. 
Western blot
For immunoblotting, cells were scraped from dishes, Ž placed in 500 ml of TE buffer 20 mmolrl Tris-HCl, pH . 7.5, 1 mmolrl EDTA and sonicated for 3 min. Where indicated, cytosolic and particulate fractions were prepared as follows: Cells were homogenized for 30 s in a Polytron tissue mincer and centrifuged for 30 min at 100 000 = g. The supernatant represented the cytosolic fraction. The pellet was resuspended in TE buffer to be used as membrane fraction, and homogenized again. The volume of both fractions was reduced by filtration in a microconcen-Ž . trator Centricon 30 Amicon, Dusseldorf, Germany tö yield 100 ml. Total protein levels in the concentrates were w x determined according to Bradford, as described 6 . Samples containing 30 mg of protein were boiled with Laemmli buffer for 5 min, and electrophoresed on 12% SDS-polyacrylamide gels. Proteins were then blotted onto Amersham Hybond-C membranes. Efficiency of transfer was verified by Ponceau red staining of the blots. The blots were blocked with 2% ovalbumin in TBS. Immunogenic signals of native bARK or 'bARKmini' were detected by probing with rabbit GRK-2 antibody directed against the COOH-terminus of bARK-1, purchased from Santa Cruz Ž . Biotechnology Santa Cruz, CA, USA , followed by perox-Ž idase-coupled secondary antibodies from Sigma, Deisen-. Ž hofen, Germany using chemoluminiscent substrate ECL, . films. Densitometric analysis of the Western blots was carried out using NIH graphics software.
Confocal laser scanning microscopy
pbARKmini-or pRK-transfected myocytes were grown in 6-well tissue culture plates on microscope cover slips for 24 h. Stimulation of the cells was carried out with 1 Ž . mmolrl y -isoproterenol in PBS. After rinsing 3 times with PBS, cells were fixed for 15 min with 4% paraformaldehyde in PBS. Cells were then permeabilized with 0.1% saponin for 10 min. To avoid non-specific antibody binding, cells were treated with 10% FCS in DMEM for Ž . 30 min prior to labelling with GRK-2 antibody 1mgrml . After incubation with goat anti-rabbit IgG FITC-conjugate Ž . Sigma, Deisenhofen, Germany , the coverslips were mounted upside-down on microscope slides and sealed with nail polish. For microscopy, samples were visualized Ž by differential interference contrast microscopy Nomarski . optics and by excitation with a low-power argon laser at 488 nm.
Digitalized microscopic images of fluorescent myocytes were analyzed densitometrically. The signal intensity in representative membrane areas was quantified as arbitrary units.
FACS
Transfected myocytes were grown on 6-well tissue culture plates for 24 h. Cells to be used for fluorescence analysis were treated as described above for immunofluorescence microscopy and removed from the plates with trypsin-EDTA prior to FACS analysis. Samples were ana-Ž . lyzed on a FACScan cytometer Becton Dickinson equipped with an argon laser. Cell signals were plotted in a forward versus side scatter, and 50 000 particles were analyzed at a rate of less than 100 events per second. A gate was defined in order to exclude all debris and aggregates. Logarithmic amplification was used for both, the fluorescence and light scatter signals. The mean intensity of immunofluorescence was used as a quantitative measure of antigen representation on cells.
cAMP accumulation in intact myocytes
pbARKmini-or pRK-transfected myocytes were grown in 6-well Falcon tissue culture plates to 80-90% confluence. They were incubated in PBS containing 1 mmolrl of the phosphodiesterase inhibitor, IBMX, for 30 min. For Ž . desensitization, cells were incubated in 1 mmolrl y -isoproterenol in PBS and IBMX for 15 min to cause maximal Ž .
Ž . were treated equally without isoproterenol. Following aspiration of the buffer, the cells were rinsed 4 times with PBS Ž . and incubated with various concentrations of y -isoproterenol for 15 min. The incubation was stopped by addition of 0.5 ml of boiling TE buffer at pH 7.5. The cells were then scraped off the plates and were separated from soluble material by centrifugation at 5000 = g for 10 min. The pellet was kept for protein determination.
The cAMP content in the supernatant was determined w 3 x by a H cAMP assay system purchased from Amersham Ž . Braunschweig, Germany according to instructions supplied by the manufacturer.
Results
Western blots
Western blotting of whole cell extracts of both DDT-MF2 smooth muscle cells and H9c2 cardiomyoblasts showed a weak, but clear signal at 80 kDa, the expected Ž . size of native bARK Fig. 1A ,B, lane 7 . A second, non-specific band at a size of f 60 kDa was obvious on cell extract blots of DDT-MF 2 cells, and was also present on blots exposed to preimmune serum instead of specific Ž . b ARK antibody Fig. 1A , lane 8 . After liposomal transfection of 0.25-5 mg pbARKmini to 100 000 DDT-MF2 smooth muscle cells or of 0.3-3 mg pbARKmini to 100 000 cardiomyoblasts, a gene dose-dependent band ap-Ž . peared at a size of 27 kDa Fig. 1A ,B, lanes 2-6 . Both native bARK signals and 'bARKmini' signals were competitively inhibited by increasing concentrations of the GRK-2 peptide. Lane 9 of Fig. 1A ,B demonstrates the effect of 10 mgrmL GRK-2 peptide on the signal of the extracts shown in lane 4. Analysis of signal intensity by laser densitometry revealed that the transfer of 0.7 mg pbARKmini to 100 000 DDT-MF 2 smooth muscle cells led to f 5.6-fold overexpression of 'bARKmini', compared to native bARK. Similarly, 2 mg pbARKmini transferred to 100 000 cardiomyoblasts led to f 5.9-fold overexpression of 'bARKmini'.
Western blotting of membrane extracts of both cell lines demonstrated a strong signal of the 'bARKmini' transgene in cytosol and a weaker signal in the membranes. Fig. 2A shows that in membranes from DDT-MF 2 smooth muscle cells transfected with control vector pRK, the signal for native bARK was increased after stimulation with 1 Ž . m molrl isoproterenol for 30 min lanes 3 and 4 . In contrast, this increase was clearly diminished in smooth muscle cells transfected with 0.7 mg pbARKminir100 000 Ž . cells lanes 1 and 2 . No detectable differences in the cytosolic immunosignal of native bARK occurred under Ž . any condition lanes 5-8 . Similarly, cardiomyoblasts transfected with 2 mg control vector pRKr100 000 cells showed an increased native bARK membrane signal after Ž . agonist exposure Fig. 2B , lanes 3 and 4 . This increase was markedly attenuated in cardiomyoblasts transfected Ž . with 2 mg pbARKminir100 000 cells lanes 1 and 2 . Again, the cytosolic signal for native bARK was not Ž . altered under any condition lanes 5-8 .
Flow cytometry
Flow cytometric analysis was performed on 50 000 cells after being detached from culture flasks. Fig. 3A demonstrates the analysis of the fluorescence intensity of DDT-MF2 smooth muscle cells which had been incubated with the secondary antibody only, or with specific GRK-2 antibody, and of myocytes which had been transfected with 0.7 mg pbARKminir100 000 cells. The smooth muscle cells which had been incubated with the specific GRK-2 antibody showed significantly higher fluorescence intensity than cells exposed to FITC antibody only. After gene transfer with pbARKmini, a second peak of nearly 10 scale units higher intensity appeared. The areas under the two curves were estimated by geometric analysis. Based upon this approximation, f 40% of the DDT-MF2 smooth muscle cells exposed to the 'bARKmini' plasmid had gained additional immuno-fluorescence intensity, corresponding to the cytoplasmic expression of 'bARKmini' in addition to native bARK.
Similarly, cardiomyoblasts showed specific immunola-Ž . belling with the GRK-2 antibody Fig. 3B . After gene transfer with 2 mg pbARKminir100 000 cardiomyoblasts, f 25% of total cells gained significantly higher specific fluorescence intensity, as estimated by geometric analysis of the surfaces under the two curves.
Confocal laser scanning microscopy
FITC-labelled cells were also subjected to confocal laser scanning microscopy. Fig. 4 shows representative light transmission and fluorescence images of DDT-MF2 smooth muscle cells transfected with either control plasmid pRK or pbARKmini and stimulated with 1 mmolrl isoproterenol or vehicle. Fig. 4A shows the absence of specific signals in cells exposed to FITC antibody only. Fig. 4B shows the largely homologous cytosolic distribu- tion of native bARK in unstimulated cells. After exposure to isoproterenol, the bARK signal was significantly translocated to the membranes, whereas less signal was Ž . found in the cytosol Fig. 4C . Translocation reached its maximum within 10 min and did not increase thereafter. After transfection with 0.7 mg pbARKminir100 000 cells, approximately 30% of the cells showed a markedly higher fluorescence signal. Such a cluster of positive cells is shown in Fig. 4D . After stimulation of 'bARKmini'-expressing cells with isoproterenol, markedly less translocation of the native bARK signal to the membranes occurred Ž . Ž . Ž . incubated either with vehicle A or GRK-2 antibody B-E , followed by FITC-labelled secondary antibody, and then subjected to confocal laser scanning Ž . Ž . microscopy. B Native bARK labelled in myocytes exposed to vehicle, only. C Membrane translocation of native bARK after exposure to isoproterenol Ž . Ž . Ž . indicated with an arrow . D Marked increase in fluorescence in a cluster of myocytes transfected with 0.7 mg pbARKminir100 000 cells. E In pbARKmini-transfected myocytes, membrane translocation of the native bARK immunosignal was attenuated. The following pseudocolour scale was used: white, high signal intensity; orange, medium signal intensity; red, low signal intensity; black, none. Ž . vehicle A or GRK-2 antibody B-E , followed by FITC-labelled secondary antibody, immobilized and then subjected to confocal laser scanning Ž . Ž . microscopy. B Native bARK labelled in myocytes exposed to vehicle only. C Membrane translocation of native bARK after exposure to isoproterenol. Ž .
Ž . D Marked increase in fluorescence in a cardiomyocyte from a batch transfected with 2 mg pbARKminir100 000 cells. E In pbARKmini-transfected cardiomyoblasts, membrane translocation of the native bARK immunosignal was clearly attenuated. The following pseudocolour scale was used: white, high signal intensity; orange, medium signal intensity; red, low signal intensity; black, none.
at Pennsylvania State University on February 21, 2013 http://cardiovascres.oxfordjournals.org/ Downloaded from ( )than 1.5 mg pbARKminir100 000 cells changed their morphology, and a significant number did not survive the gene transfer. Lower concentrations of pbARKmini, however, did not change cell morphology detectably.
Also in cardiomyoblasts, native bARK was translocated Ž . after agonist stimulation Fig. 5B,C . Fig. 5C demonstrates that stimulation with isoproterenol led to a somewhat asymmetrical increase in the bARK signal to one side of the membrane. This was a typical finding in almost all stimulated cardiomyoblasts investigated. Additionally, the cytosolic bARK signal appeared more granular after agonist stimulation, possibly corresponding to an internal translocation of bARK to intracellular microsomal strucw x tures, as suggested by some authors 16,17 . Again, translocation reached its maximum within 10 min. After transfection with 2 mg pbARKminir100 000 cells, nearly 25% of the transfected cells gained markedly higher bARK Ž . 2 myocytes A and cardiomyoblasts B . 100 000 myocytes were either Ž . Ž . Ž . transfected with 0.7 mg A or 2 mg B pbARKmini black symbols , or Ž . control plasmid pBC white symbols . The cells were then grown in 6-well plates; 48 h later, the myocytes were exposed either to vehicle Ž . Ž . circles or to 1 mmolrl isoproterenol squares . The cells were washed thoroughly, and formation of cAMP was measured in the presence of increasing concentrations of isoproterenol. Data are means of 3 experiments, each carried out in triplicate, "s.e.m. ) P F 0.05 pbARKmini vs. pRK, ) ) P -0.02 desensitized vs. non-desensitized.
immunofluorescence, due to the additional expression of Ž . ' b ARKmini' Fig. 5D . 'bARKmini'-expressing cardiomyoblasts showed no detectable translocation of the Ž . native bARK signal after agonist stimulation Fig. 5E . Densitometric analysis of the membrane areas of 'bARKmini'-expressing and 'bARKmini'-negative cells after agonist stimulation showed significantly higher signal Ž intensity in cells which did not express 'bARKmini' Fig. . 6B . Higher doses of pbARKmini) 5 mgr100 000 cardiomyoblasts were cytotoxic.
Adenylyl cyclase desensitization
cAMP concentrations were measured in intact myocytes after stimulation with isoproterenol. Fig. 7 demonstrates that isoproterenol in concentrations ranging from 0.001 to 10 mmolrl led to intracellular accumulation of cAMP. On average, cAMP levels were raised from 1 to 38 pmolrmg protein in DDT-MF2 smooth muscle cells, and from 13 to 50 pmolrmg protein in cardiomyoblasts. In DDT-MF2 smooth muscle cells transfected with 0.7 m g Ž pbARKminir100 000 cells corresponding to f 5.6-fold overexpression of 'bARKmini' vs. native bARK, as esti-. mated from Western blots , basal and isoproterenol-induced Fig. 8 . Analysis of isoproterenol-induced cAMP formation in DDT-MF 2 Ž . myocytes. 100 000 myocytes were either transfected with 0.1 mg A or Ž . 0.7 mg B or 1.5 mg pbARKmini, resulting in 1-, 5.6-and 15-fold overexpressions of 'bARKmini' vs. native bARK. The cells were then grown in 6-well plates; 48 h later, the myocytes were exposed either to Ž . Ž . vehicle circles or to 1 mmolrl isoproterenol squares . The cells were washed thoroughly, and formation of cAMP was measured in the presence of increasing concentrations of isoproterenol. Similar results were obtained in cardiomyoblasts. ) P -0.02 desensitized vs. non-desensitized. maximal cAMP levels were unaltered, with EC values 50 ranging from 100 to 150 nmolrl. When the cells were desensitized by preincubation with isoproterenol for 15 min, the response to a subsequent, repeated exposure to the b-agonist was markedly blunted. This desensitization reached significance only in pRK-transfected smooth mus-Ž . cle cells P -0.02 , whereas cAMP accumulation after agonist exposure did not differ significantly in pbARKmini-transfected cells. After prior exposure to isoproterenol, 'bARKmini'-transfected cells accumulated sig-Ž . nificantly more cAMP Fig. 7A , P -0.05 . When cells were transfected with lower gene concentrations of Ž pbARKmini 0.1 mgr100 000 cells, corresponding to equal . expression of 'bARKmini' and bARK , they could still be subjected to significant desensitization, accumulating significantly less cAMP after pre-exposure to isoproterenol Ž . P -0.05, Fig. 8A . pbARKmini doses exceeding 1.5 Ž m gr100 000 cells f 15-fold overexpression of . 'bARKmini' led to a change in cell morphology, and to a Ž . decrease in cAMP response to isoproterenol Fig. 8C .
Similarly, cAMP accumulation was identical in cardiomyoblasts transfected with 2 mg pbARKminir100 000 Ž cells corresponding to f 5.9-fold overexpression of . 'bARKmini' , and in cells transfected with 2 mg of pRK. Also in cardiomyoblasts, expression of 'bARKmini' did not affect regular b-adrenergic stimulation. After pre-exposure to isoproterenol, however, the cAMP response elicited by isoproterenol was significantly higher in pbARKmini-transfected cardiomyoblasts than in pRK-Ž . transfected cardiomyoblasts Fig. 7B . Expression of 'bARKmini' led to a virtually complete reversion of desensitization. In contrast, cardiomyoblasts transfected with Ž 0.1 or 0.3 mg of pbARKmini corresponding to f 0.7-and f 1.1-fold overexpression of 'bARKmini', respec-. tively showed a pattern of desensitization which did not Ž . differ significantly from that of control cells not shown .
Discussion
The present study characterizes bARK translocation in intact myocytes, as detected by immunofluorescence labelling. bARK translocation and b-adrenergic desensitization could be inhibited effectively by a plasmid-induced expression of the inhibitor protein, 'bARKmini', in intact myocytes and cardiomyoblasts. Transfection of more than 0.7 mg of pbARKmini to 100 000 DDT-MF 2 smooth muscle cells, and of 2 mg of pbARKmini to 100 000 cardiomyoblasts led to sufficient expression of this protein to significantly attenuate endogenous b-adrenergic desensitization in these myocytes.
bARK selectively phosphorylates and thereby inactivates agonist-occupied b-adrenergic receptors. This process has been linked to translocation of the enzyme from a w x cytosolic compartment to the membranes 1 . We have demonstrated that specific antibodies can be used to effectively label bARK in permeabilized smooth muscle cells and cardiomyoblasts. Confocal laser images of these cells suggest that bARK is actually translocated rapidly to the myocytic membrane after b-agonist stimulation. In DDT-MF2 smooth muscle cells, which display a narrow cytoplasm, translocation seemed to be directed to all sides of the myocyte, and the cytosol appeared to clear rapidly of the bARK immunosignal after agonist exposure. Since small cytoplasmic margins compromise the microscopic differentiation between cytosol and membranes, we compared these effects with another myocytic cell line with larger cytoplasm. Our data corroborate the results of an earlier publication on the translocation of bARK activity in DDT-MF2 smooth muscle cells after b-adrenergic stimw x ulation 18 .
In cardiomyoblasts, which possess a pronouncedly larger cytoplasm, translocation appeared asymmetrical in all cells investigated. The homogeneous cytosolic distribution of the bARK immunosignal seemed to assume a more granular appearance after the agonist challenge, possibly corresponding to an internal translocation to a microsomal w x compartment, as suggested by others 16,17 . This issue can, however, not be decided with certainty, since the spatial resolution of fluorescence imaging is limited. Translocation reached a maximum within 10 min and was not further increased thereafter. This time course corresponds quite well with previous studies in which the capacity of cell extracts to phosphorylate rhodopsin or b -adrenergic receptors was used to determine bARK Considerable interest has evolved in inhibiting cardiac bARK activation since overexpression of the inhibitor protein 'bARKmini' has been shown to increase cardiac w x contractility in transgenic mice 14 . These animals, however, developed high constitutive expression of 'bARKmini', since the transgene was coupled to the amyosin heavy chain promotor which was active during the entire life of the animals. Our study shows that also external plasmid-derived gene transfer of 'bARKmini', which leads to less expression of the inhibitor protein, can effectively inhibit b-adrenergic desensitization in intact myocytes. Our results demonstrate that the effect of 'bARKmini' can be tested biochemically by estimating the amount of immunolabelled bARK which translocates after agonist stimulation, and by quantifying intramyocytic cAMP accumulation after previous desensitization. This finding is of some relevance, since measurement of adenylyl cyclase activity in membranes prepared from 'bARKmini'-transgenic and control hearts did not reveal w x any differences 14 . Normal cAMP accumulation was not affected by 'bARKmini', but sustained cAMP formation after prolonged agonist stimulation occurred. Therefore, 'bARKmini' might interact specifically with the mechanisms which lead to rapid b-adrenergic refractoriness in heart failure. We conclude that the analysis of single myocytes contributes to the understanding of the biological effects of 'bARKmini' in cardiomyocytes.
The amount of plasmid needed for the expression of 'bARKmini' in biologically relevant concentrations was titered to be 0.7 mg for 100 000 DDT myocytes, and 2 mg for 100 000 cardiomyoblasts, corresponding to similar Ž overexpressions of 'bARKmini' vs. native bARK 5.6-. and 5.9-fold, respectively . Since several reports have described the possibility of cardiac gene expression after w x direct plasmid injection 20,21 , the direct application of a plasmid by intracardiac injection might suffice to attenuate b-adrenergic desensitization in vivo. This information about gene effects in cardiomyocytes should be useful for further studies, since several investigators have described a gene concentration-dependency of plasmid-derived expression of recombinant proteins in vivo. Such an example was given recently by the successful transfer of a plasmid encoding VEGF into the popliteal artery of a patient, leading to enhanced collateralisation and better clinical w x outcome 22 . In this study, effects started at a plasmid dose of 2000 mg. An even higher biological effect of 'bARKmini' can be expected from future experiments with viral transfer systems which will allow even more efficient gene transfer to a higher percentage of cells.
Limitations of the study
In the present study, we distinguished the signals of 'bARKmini' and of native bARK by their sizes on Western blots, and by their localisation by confocal laser microscopy. On Western blots, the bulk of 'bARKmini' was found in the cytosolic fraction. A small amount of 'bARKmini' in the particulate fraction is probably due to massive overexpression of the protein, and to minor contamination during preparation. This is in line with previous w x studies 13 , since 'bARKmini' is known to be a strictly cytosolic protein which lacks all components necessary for membrane translocation, namely the site of isoprenylation. Therefore, the translocation observed by means of Ž immunofluorescence i.e., the gain in membrane signal . after agonist stimulation can be assumed to be due to translocation of native bARK. In contrast, the cytosolic signal for native bARK could not be studied in 'bARKmini'-expressing cells by confocal microscopy. This signal could, however, be differentiated on Western blots of cytosolic fractions.
Note added in proof
During the review process of the present manuscript, an extensive study on the effect of adenoviral transfer of 'bARKmini' to cardiomyocytes was published. This paper corroborates our data on the effects of 'bARKmini' on Ž b-adrenergic desensitization Drazner et al., J Clin Invest . 1997;99:288-296 . 
